SS-31 (Elamipretide)
300mg/6ml vial.
SS-31 is a specialized mechanic for your cellular engines. Unlike most peptides that work through receptors, SS-31 binds directly to cardiolipin in mitochondrial membranes, stabilizing energy production at the cellular level. Supports ATP production, reduces oxidative stress.
Interested in SS-31 (Elamipretide)?
Our medical team will evaluate if this medication is right for you during your consultation.
Dosage & Administration
Daily subcutaneous injections for 8-12 weeks. Dose range: 5-10mg daily (standard); 15-20mg daily (advanced, under supervision). Keep refrigerated. Because it binds to fats rather than receptors, your body doesn't build tolerance — no cycling required.
Important: Like any prescribed medication, dosing varies from person to person. Always follow the dosage prescribed by your healthcare provider. Optimize 360 personalizes every protocol based on your labs, symptoms, and goals.
Side Effects
- Injection Site Reactions (most common): ~80% of clinical trial patients experienced mild-to-moderate redness, itching, or swelling.
- No dose-limiting toxicities or serious adverse events directly attributed to SS-31 in clinical trials.
- Note: Long-term safety data beyond 12 weeks remains limited; extended use requires monitoring.
Why Choose Optimize 360 for SS-31 (Elamipretide)
- Prescribed and monitored by Dr. Steve Farmer — 30+ years in hormone medicine
- Comprehensive lab work before prescribing — we never guess
- Sourced from licensed U.S. compounding pharmacies
- Transparent pricing — the price above is what you pay, no hidden fees
- Telehealth available nationwide — medications shipped to your door
- Unlimited messaging with your provider throughout treatment
Get Started Today
No memberships. No referral needed. Schedule your consultation and we'll take it from there.
Related
How SS-31 Works
SS-31 (elamipretide) is a mitochondria-targeted peptide that selectively concentrates in the inner mitochondrial membrane. It binds to cardiolipin, a phospholipid essential for maintaining the structure and function of the electron transport chain — the cellular machinery that produces ATP (energy). With aging, cardiolipin becomes oxidized and disorganized, leading to impaired mitochondrial function, reduced energy production, and increased oxidative stress. SS-31 stabilizes cardiolipin, restores electron transport efficiency, reduces reactive oxygen species (ROS) production, and improves overall mitochondrial output.
Benefits & Clinical Evidence
Preclinical research has demonstrated that SS-31 improves mitochondrial function across multiple organ systems — heart, kidney, skeletal muscle, brain, and retina. Animal studies show improved cardiac output, enhanced exercise capacity, reduced age-related muscle weakness, and neuroprotective effects. In human clinical trials for Barth syndrome (a mitochondrial cardiomyopathy), elamipretide showed improvements in exercise tolerance and cardiac function. Research in age-related mitochondrial decline suggests SS-31 may help restore cellular energy production toward more youthful levels. It represents a fundamentally different approach to anti-aging — targeting the organelle most responsible for cellular energy.
Who Is a Good Candidate?
SS-31 may benefit patients experiencing age-related fatigue that is not fully explained by hormonal deficiency, those with reduced exercise capacity despite adequate fitness efforts, patients interested in cellular-level longevity strategies, and individuals with conditions associated with mitochondrial dysfunction. It is particularly relevant for patients over 40 whose energy decline persists despite optimized hormones, adequate sleep, and proper nutrition — suggesting mitochondrial-level dysfunction. Both men and women are candidates for SS-31 therapy.
What to Expect: Treatment Timeline
Some patients report subtle improvements in energy and exercise recovery within 1-2 weeks. Mitochondrial adaptations develop progressively over 4-12 weeks. Because SS-31 works at the cellular organelle level, benefits may be more gradual and systemic than therapies targeting hormones or neurotransmitters. Many patients describe a general sense of improved vitality and resilience rather than a dramatic acute effect. Typical protocols involve daily subcutaneous injections for 8-12 week cycles. Available at Optimize 360 from $562.50/vial.
Side Effects & Safety
SS-31 is generally well tolerated in clinical use. The most commonly reported side effects are injection site reactions and occasional headache. In clinical trials for Barth syndrome, the safety profile was favorable with no serious drug-related adverse events at therapeutic doses. As a relatively newer peptide therapy, long-term safety data in healthy aging populations is still accumulating. All SS-31 at Optimize 360 is pharmacy-compounded from licensed US facilities, with medical supervision and lab monitoring throughout treatment.
Frequently Asked Questions
A: Most anti-aging therapies target hormones, antioxidants, or cellular signaling pathways. SS-31 targets the mitochondria directly — the organelles responsible for 90% of cellular energy production. By stabilizing the inner mitochondrial membrane, it addresses energy production at its source rather than downstream effects of mitochondrial decline.
A: Yes. SS-31 and NAD+ work on complementary aspects of mitochondrial function. NAD+ supports the enzymatic reactions that drive energy metabolism, while SS-31 stabilizes the physical structure of the electron transport chain. Together, they may provide a more comprehensive approach to mitochondrial restoration than either alone.
A: SS-31's synthesis is more complex than many other peptides, and its mitochondria-targeting mechanism requires specific structural precision. The cost reflects manufacturing complexity and the specialized compounding required. Your provider can help you assess whether SS-31 is an appropriate investment based on your health goals and current protocol.
Also Available